WallStSmart
PCVX

Vaxcyte Inc

NASDAQ: PCVX · HEALTHCARE · BIOTECHNOLOGY

$57.32
-2.40% today

Updated 2026-04-29

Market cap
$8.28B
P/E ratio
P/S ratio
EPS (TTM)
$-5.63
Dividend yield
52W range
$28 – $65
Volume
1.3M

Vaxcyte Inc (PCVX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-14.8%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-76.9%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-6.7%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-11.0%
2025-08-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-02$-1.80-22.4%$61.74$59.82-3.1%
2025-11-04$-1.56-25.8%$42.83$40.32-5.9%
2025-08-06$-1.22-4.3%$33.73$30.01-11.0%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.47$-1.80-22.4%
2025-09-30$-1.24$-1.56-25.8%
2025-06-30$-1.17$-1.22-4.3%
2025-03-31$-0.98$-1.04-6.7%
2024-12-31$-0.99$-1.02-2.6%
2024-09-30$-1.13$-0.83+26.5%
2024-06-30$-0.98$-1.10-12.2%
2024-03-31$-1.17$-0.85+27.4%
2023-12-31$-1.07$-1.82-70.1%$14.45M
2023-09-30$-0.84$-0.91-8.3%
2023-06-30$-0.74$-0.70+5.4%
2023-03-31$-0.83$-0.70+15.7%

Frequently asked questions

Has Vaxcyte Inc beaten earnings estimates?
Vaxcyte Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -14.8% over the last 4 quarters.
How does PCVX stock react to earnings?
PCVX stock has moved an average of -6.7% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.